• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 424B3 filed by Nakamoto Inc.

    1/30/26 8:52:38 PM ET
    $NAKA
    Medical/Nursing Services
    Health Care
    Get the next $NAKA alert in real time by email
    424B3 1 form424b3.htm 424B3

     

    PROSPECTUS SUPPLEMENT

    To Prospectus dated May 6, 2025

    Filed Pursuant to 424(b)(3)

    Registration No. 333-274606

     

    NAKAMOTO INC.

     

    2,059,811 Shares of Common Stock Issuable Upon Exercise of Previously Issued Warrants

    and

    82,310 Shares of Common Stock

     

    This prospectus supplement updates and supplements the information contained in the prospectus dated May 6, 2025 (as may be supplemented or amended from time to time, the “Prospectus”), which forms part of our registration statement on Form S-1 (File No. 333-274606), as amended, with the information contained in our Current Report on Form 8-K which was filed with the Securities and Exchange Commission on January 30, 2026 (the “Current Report”). Accordingly, we have attached the Current Report to this prospectus supplement.

     

    The Prospectus and this prospectus supplement relate to the issuance by Nakamoto Inc., a Delaware corporation, of up to 2,059,811 shares of common stock underlying the tradeable warrants (the “Tradeable Warrants”), the non-tradeable warrants (the “Non-tradeable Warrants”) and the representative’s warrants (the “Representative’s Warrants” and, together with the Tradeable Warrants and the Non-tradeable Warrants, the “Warrants”) previously issued by us in our initial public offering that closed on June 3, 2024. We are not selling any shares of our common stock in this offering, and, as a result, we will not receive any proceeds from the sale of the common stock covered by this prospectus. All of the net proceeds from the sale of our common stock will go to the holders of the Warrants. Upon exercise of the Warrants, however, we will receive proceeds from the exercise of such Warrants if exercised for cash.

     

    The Prospectus and the prospectus supplement also relate to the resale from time to time by the selling stockholders named in the Prospectus (the “Selling Stockholders”) of 82,310 shares of common stock. We will not receive any proceeds from the sale of shares of common stock by the Selling Stockholders pursuant to the Prospectus.

     

    You should read this prospectus supplement in conjunction with the Prospectus. This prospectus supplement is qualified by reference to the Prospectus except to the extent that the information in this prospectus supplement supersedes the information contained in the Prospectus. This prospectus supplement is not complete without, and may not be delivered or utilized except in connection with, the Prospectus. If there is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement. Terms used in this prospectus supplement but not defined herein shall have the meanings given to such terms in the Prospectus.

     

    Our common stock is listed on the Nasdaq Capital Market (“Nasdaq”) under the symbol “NAKA.” The last reported sale price of our common stock on Nasdaq on January 29, 2026 was $0.37 per share. Our Tradeable Warrants are quoted on the OTC Pink marketplace (“OTC”) under the symbol “NAKAW.” The last reported sale price of our Tradeable Warrants on OTC on January 29, 2026 was $1.89 per warrant.

     

    Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 20 of the Prospectus and in the other documents that are incorporated by reference in the Prospectus.

     

    Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the securities to be issued under the Prospectus or determined if the Prospectus or this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.

     

    The date of this prospectus supplement is January 30, 2026.

     

     

     

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C.

     

    FORM 8-K

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d) OF

    THE SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): January 30, 2026

     

    Nakamoto Inc.

    (Exact name of registrant as specified in its charter)

     DE

    001-42103   84-3829824

    (Commission

    File Number)

     

    (IRS Employer

    Identification Number)

         
    300 10th Ave South, Nashville, TN   37203
    (Address of Principal Executive Offices)   (Zip Code)

     

    615-676-8668

    (Registrant’s telephone number, including area code)

     

    Not Applicable

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of Each Class   Trading Symbol(s)   Name of Each Exchange on Which Registered
    Common Stock, par value $0.001   NAKA   The Nasdaq Stock Market LLC
    Tradeable Warrants to purchase shares of Common Stock, par value $0.001 per share   NAKAW   OTC Pink Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 1.01. Entry into a Material Definitive Agreement.

     

    Amendment No. 1 to the Master Loan Agreement

     

    On January 30, 2026, Nakamoto Inc., a Delaware corporation, through its wholly owned subsidiary, Nakamoto Holdings, Inc. (“Nakamoto Holdings”), entered into that certain First Amendment to the Master Loan Agreement (the “MLA Amendment”), which amends that certain Master Loan Agreement, dated as of December 3, 2025 (the “Master Loan Agreement”), by and between Nakamoto Holdings and Payward Interactive, Inc. (the “Lender”).

     

    The MLA Amendment amends the Master Loan Agreement to permit the funding of a designated trading wallet maintained at the Lender (the “Trading Wallet”) and to clarify that the Trading Wallet shall serve as collateral for both the obligations under the Master Loan Agreement and obligations (if any) resulting from trading activity conducted through such wallet.

     

    The foregoing description of the MLA Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the MLA Amendment, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    Exhibit No.   Description of Exhibit
    10.1   First Amendment to the Master Loan Agreement, dated as of January 30, 2026, by and between Nakamoto Holdings, Inc. and Payward Interactive, Inc.
    104   The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunder duly authorized.

     

      NAKAMOTO INC.
         
    Dated: January 30, 2026 By: /s/ David Bailey
        David Bailey
        Chief Executive Officer

     

     

     

     

    Exhibit 10.1

     

    FIRST AMENDMENT TO MASTER LOAN AGREEMENT

     

    THIS FIRST AMENDMENT (this “Amendment”) is made as of January 30, 2026 and amends that certain Master Loan Agreement dated as of December 3, 2025 (the “Master Loan Agreement”) between Payward Interactive, Inc. (“Lender”), a Florida corporation, and Nakamoto Holdings Inc. (“Borrower”), a corporation organized and existing under the laws of Delaware, with its principal place of business at 5097 South 900 East, Suite 100, Salt Lake City, UT 84117. Lender and Borrower are each individually a “Party” and, collectively, the “Parties” hereunder.

     

    RECITALS

     

    A. The Lender and the Borrower are parties to the Master Loan Agreement. Capitalized terms used herein without definition have the meanings assigned to them in the Master Loan Agreement.

     

    B. The parties hereto desire to amend the Master Loan Agreement on the terms and conditions as hereinafter set forth.

     

    NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

     

    I. Amendments to Master Loan Agreement.

     

      A. Section I of the Master Loan Agreement is hereby amended by inserting the following definitions in alphabetical order:

     

    “Advisor” means Bitwise Investment Advisers, LLC, as commodity account manager and attorney-in-fact for Borrower.

     

    “CSA” means the ISDA Credit Support Annex (ISDA Agreements Subject to New York Law Only) to the Schedule to the Master Agreement, as may be amended, supplemented or otherwise modified from time to time.

     

    “Master Agreement” means the 2002 ISDA Master Agreement between the Advisor and POL, which includes a Schedule and a Credit Support Annex (or “CSA”) to the Schedule and which incorporates by reference as a single agreement all Transactions (as defined in the Master Agreement) executed thereunder from time to time, as any of the foregoing may be amended, supplemented or otherwise modified from time to time.

     

    “POL” means Payward Oceanic Ltd.

     

    “Secured Parties” means Lender and POL (and their respective successors and assigns).

     

      B.

    Section IV(a) of the Master Loan Agreement is hereby amended to add the following as the last sentence to the first paragraph of Section IV(a):

     

    For the avoidance of doubt, all Collateral that is pledged to the Lender hereunder and to the Secured Parties under the Master Agreement and CSA shall be included in the calculation of Collateral Value for purposes of determining the Margin Ratio hereunder.

     

      C. The first sentence of the first paragraph of Section IV(b) of the Master Loan Agreement is hereby amended and restated to read in its entirety as follows:

     

    As security for the prompt and complete payment by Borrower of (i) the Loaned Currency in respect of a Loan, all related fees, expenses and indemnities due hereunder, and all other obligations owing by Borrower to Lender hereunder or under any other Loan Document, and (ii) all obligations of Borrower to POL under the Master Agreement, Borrower hereby pledges, collaterally assigns and grants to the Secured Parties a continuing first priority perfected security interest in, and a lien upon, Borrower’s right, title and interest in and to, or otherwise with respect to, the Collateral (including any Additional Collateral), whether now owned or existing or hereafter acquired or arising and regardless of where located (the “Security Interest”).

     

     

     

     

      D. Section IV(f)(iii) of the Master Loan Agreement is hereby amended and restated to read in its entirety as follows:

     

    (iii) the proceeds of the sale of Collateral, less the Liquidation Fee, shall be applied to Borrower’s obligations hereunder and/or under the Master Agreement in any order as Lender may determine in its sole discretion.

     

      E. Section VII(k) of the Master Loan Agreement is hereby amended and restated to read in its entirety as follows:

     

    Borrower has, or will have at the time of transfer of any Collateral, the right to grant a first priority security interest therein and the right to transfer such Collateral pursuant to the terms and conditions hereof, free and clear of all liens and encumbrances other than those arising under this Agreement and/or under the CSA. Except with respect to the financing statements filed by the Secured Parties, no financing statement covering any of the Collateral or any proceeds thereof is or will be on file in any public office.

     

      F. Section VIII(p) of the Master Loan Agreement is hereby amended and restated to read in its entirety as follows:

     

    (p) Creation of Liens. Borrower shall not create or suffer to exist any lien or transfer upon or against any of the Collateral in violation of this Agreement. Notwithstanding anything to the contrary in the foregoing, the following liens are permitted: (a) liens arising as a matter of law (other than liens arising out of violations by Borrower of Applicable Law) incurred in the ordinary course of business and (b) liens on the Collateral in favor of the Secured Parties.

     

      G. Section IX(o) of the Master Loan Agreement is hereby amended by deleting the “or” at the end thereof; by adding “or” to the end of Section IX(p) and by adding new Section IX(q) to the end thereof as follows:

     

    (q) the occurrence of an Early Termination Date under the Master Agreement.

     

      H. The second sentence of Section X(b) of the Master Loan Agreement is hereby amended and restated to read in its entirety as follows:

     

    The proceeds of the sale of Collateral by Lender shall be applied to Borrower’s obligations hereunder and under the Master Agreement in any order as Lender may determine in its sole discretion.

     

    II. No Further Amendments.

     

    Except as specifically amended hereby, the Master Loan Agreement shall remain unmodified and in full force and effect and the Master Loan Agreement and each of the other Loan Documents are hereby ratified and affirmed in all respects, and the indebtedness and other Obligations of Borrower to Lender evidenced thereby are hereby reaffirmed in all respects.

     

    -2-

     

     

    III. Certain Representations.

     

    Borrower hereby represents and warrants to Lender (which representations and warranties shall survive the delivery of this Amendment), after giving effect to this Amendment, as follows:

     

    A. The execution and delivery of this Amendment have been duly authorized by all requisite corporate action on the part of Borrower.

     

    B. The representations and warranties contained in the Master Loan Agreement and the other Loan Documents are true and correct in all material respects on and as of the date of this Amendment as though made at and as of such date (except to the extent that such representations and warranties expressly relate to an earlier date).

     

    C. This Amendment constitutes the legal, valid and binding obligation of Borrower, enforceable against Borrower in accordance with its terms, subject to bankruptcy, insolvency, reorganization, moratorium and similar laws affecting the rights and remedies of creditors generally or the application of principles of equity, whether in any action at law or proceeding in equity, and subject to the availability of the remedy of specific performance or of any other equitable remedy or relief to enforce any right thereunder. No consent, approval, authorization or order of, or filing, registration or qualification with, any court or governmental authority or third party is required in connection with the execution, delivery or performance by Borrower of this Amendment.

     

    IV. Miscellaneous.

     

    A. This Amendment shall be governed by and construed in accordance with the law specified in the Master Loan Agreement.

     

    B. This Amendment may be executed in any number of counterparts and by different parties on separate counterparts, each of which, when executed and delivered, shall be deemed to be an original, and all of which, when taken together, shall constitute but one and the same instrument. Delivery of an executed counterpart of this Amendment by email or other electronic method of transmission (including email transmission of a PDF image or the use of a third-party platform, including DocuSign) shall be equally as effective as delivery of an original executed counterpart of this Amendment. The words “execute,” “execution,” “signed,” “signature,” and words of like import in or related to any document to be signed in connection with this Amendment and the transactions contemplated hereby shall be deemed to include electronic signatures, deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the California Uniform Electronic Transactions Act, or any other similar state laws based on the Uniform Electronic Transactions Act. The parties hereto consent to the use of electronic signatures and records with respect to this Amendment.

     

    * The next page is the signature page *

     

    -3-

     

     

    IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as a sealed instrument by their duly authorized representatives, all as of the day and year first above written.

     

      PAYWARD INTERACTIVE, INC.
         
      By:

    /s/ Cynthia Del Pozo

      Name: Cynthia Del Pozo
      Title: Chief Executive Officer and President

     

      NAKAMOTO HOLDINGS INC.
         
      By:

    /s/ Tyler Evans

      Name:

    Tyler Evans

      Title: Chief Executive Officer and President

     

     

     

     

    Get the next $NAKA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NAKA

    DatePrice TargetRatingAnalyst
    10/16/2025$2.00Buy
    B. Riley Securities
    9/3/2025$8.00Buy
    Maxim Group
    More analyst ratings

    $NAKA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Dalton John Merritt was granted 1,574,803 shares (SEC Form 4)

    4 - Kindly MD, Inc. (0001946573) (Issuer)

    12/18/25 8:14:39 PM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    Chief Financial Officer Gendron Teresa S was granted 2,624,671 shares (SEC Form 4)

    4 - Kindly MD, Inc. (0001946573) (Issuer)

    12/18/25 8:13:20 PM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    SEC Form 3 filed by new insider Gendron Teresa S

    3 - Kindly MD, Inc. (0001946573) (Issuer)

    12/9/25 7:36:04 PM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    $NAKA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    KindlyMD Announces Authorization of Share Repurchase Program

    Program Enhances Financial Flexibility and Reflects Confidence in Long-Term Bitcoin Operations KindlyMD, Inc. (NASDAQ:NAKA) ("KindlyMD" or "the Company"), a provider of integrated healthcare services and a Bitcoin company via its subsidiary Nakamoto Holdings, Inc. ("Nakamoto"), today announced that its Board of Directors (the "Board") has authorized a share repurchase program under which the Company may repurchase its outstanding common stock. "This share repurchase program reflects our confidence in the long-term value of the Company and adds an important degree of flexibility to our capital allocation framework," said David Bailey, Chairman and CEO of KindlyMD. "As shareholders ourselve

    12/18/25 8:00:00 AM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    KindlyMD Strengthens Leadership Team with Senior Finance Talent

    Former Jefferies Financial Group Executives Teri Gendron and John Dalton Join as Chief Financial Officer and Chief Accounting Officer & Controller, Respectively KindlyMD, Inc. (NASDAQ:NAKA) ("KindlyMD" or the "Company"), a provider of integrated healthcare services and a Bitcoin treasury company via its subsidiary Nakamoto Holdings, Inc. ("Nakamoto"), today announced the appointments of Teri Gendron, former Chief Financial Officer of Markel Group Inc. and Jefferies Financial Group Inc., as Chief Financial Officer and Treasurer, and John Dalton, former Chief Financial Officer of Jefferies Finance LLC, as Chief Accounting Officer and Controller, effective immediately. Together, they bring de

    12/8/25 8:00:00 AM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    KindlyMD Reports Third Quarter 2025 Operational and Financial Results

    Completed Merger with Bitcoin Treasury Company Nakamoto Advanced Mission of Building Leading Bitcoin Ecosystem Through Accumulation of 5,398 Bitcoin in Treasury and Completion of Two Strategic Investments KindlyMD, Inc. (NASDAQ:NAKA) ("KindlyMD" or "the Company"), a provider of integrated healthcare services and a Bitcoin treasury company via its subsidiary Nakamoto Holdings, Inc. ("Nakamoto"), today announced its financial and operating results for the quarter ended September 30, 2025, along with an update on its Bitcoin treasury strategy. In May 2025, KindlyMD took a major strategic leap when it announced its merger with Nakamoto and subsequently raised approximately $540 million of

    11/19/25 4:30:00 PM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    $NAKA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley Securities initiated coverage on Kindly MD (dba Nakamoto) with a new price target

    B. Riley Securities initiated coverage of Kindly MD (dba Nakamoto) with a rating of Buy and set a new price target of $2.00

    10/16/25 8:26:43 AM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    Maxim Group initiated coverage on Kindly MD (dba Nakamoto) with a new price target

    Maxim Group initiated coverage of Kindly MD (dba Nakamoto) with a rating of Buy and set a new price target of $8.00

    9/3/25 8:05:07 AM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    $NAKA
    SEC Filings

    View All

    SEC Form 424B3 filed by Nakamoto Inc.

    424B3 - Nakamoto Inc. (0001946573) (Filer)

    1/30/26 8:52:38 PM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    Nakamoto Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Nakamoto Inc. (0001946573) (Filer)

    1/30/26 8:05:41 PM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    SEC Form 424B3 filed by Nakamoto Inc.

    424B3 - Nakamoto Inc. (0001946573) (Filer)

    1/23/26 4:05:26 PM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    $NAKA
    Leadership Updates

    Live Leadership Updates

    View All

    BTC Inc Appoints Brandon Green as Chief Executive Officer

    Reports Significant Year-to-Date Growth in Revenue and Global Audience Engagement BTC Inc (the "Company"), the leading provider of Bitcoin-related news and events, today announced the appointment of Brandon Green as Chief Executive Officer, effective immediately. In this role, Green will oversee the Company's strategic and operational direction, including leading the continued growth of Bitcoin Magazine and the global Bitcoin Conference series. As part of this leadership transition, David Bailey, Chairman and CEO of KindlyMD (NASDAQ:NAKA) and Co-Founder of BTC Inc, will step down as Chief Executive Officer of BTC Inc and continue to serve as the Company's Chairman of the Board, supporti

    11/17/25 11:01:00 AM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    Treasury Revolution Sparks 150% Stock Surges as Corporate Bitcoin Holdings Hit $113 Billion

    Equity Insider News Commentary Issued on behalf of CEA Industries, Inc. VANCOUVER, BC, Sept. 10, 2025 /PRNewswire/ -- Corporate treasury companies surge an average of 150% within 24 hours of announcing crypto adoption strategies, according to a 2025 Animoca Brands report[1], as digital asset treasuries amass $113 billion in Bitcoin stockpiles through September 2025[2]. The explosive momentum reflects a fundamental shift from traditional cash reserves to strategic cryptocurrency accumulation, with Crypto.com reporting over 90 public companies now holding Bitcoin on their balance sheets[3] as corporate America embraces digital assets as inflation hedges and growth catalysts. This treasury tran

    9/10/25 9:32:00 AM ET
    $BNC
    $CIFR
    $NAKA
    Industrial Machinery/Components
    Industrials
    Finance: Consumer Services
    Finance

    Nakamoto Holdings Appoints Andrew Creighton as Chief Commercial Officer to Lead Global Bitcoin Growth Strategy

    Nakamoto Holdings Inc. ("Nakamoto"), a Bitcoin-native holding company, which previously announced its anticipated merger with Kindly MD, Inc. (NASDAQ:NAKA) ("KindlyMD"), today announced the appointment of Andrew Creighton as Chief Commercial Officer. In this role, Andrew will lead Nakamoto's commercial strategy across global markets, including overseeing licensing, partnerships, capital formation, and regional expansion. Andrew is a seasoned operator with deep expertise in scaling international businesses, raising institutional capital, and securing transformational partnerships. He currently serves as Chief Commercial Officer of BTC Inc, publisher of Bitcoin Magazine and host of the annu

    6/25/25 9:00:00 AM ET
    $NAKA
    Medical/Nursing Services
    Health Care